251 related articles for article (PubMed ID: 24161911)
1. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
[TBL] [Abstract][Full Text] [Related]
2. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Gene Expression Analysis Shows AKAP13-Mediated PKD1 Signaling Regulates the Transcriptional Response to Cardiac Hypertrophy.
Johnson KR; Nicodemus-Johnson J; Spindler MJ; Carnegie GK
PLoS One; 2015; 10(7):e0132474. PubMed ID: 26192751
[TBL] [Abstract][Full Text] [Related]
4. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
Carnegie GK; Soughayer J; Smith FD; Pedroja BS; Zhang F; Diviani D; Bristow MR; Kunkel MT; Newton AC; Langeberg LK; Scott JD
Mol Cell; 2008 Oct; 32(2):169-79. PubMed ID: 18951085
[TBL] [Abstract][Full Text] [Related]
5. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
Burmeister BT; Taglieri DM; Wang L; Carnegie GK
J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
[TBL] [Abstract][Full Text] [Related]
6. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
Cavin S; Maric D; Diviani D
Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
[TBL] [Abstract][Full Text] [Related]
7. AKAP13 Rho-GEF and PKD-binding domain deficient mice develop normally but have an abnormal response to β-adrenergic-induced cardiac hypertrophy.
Spindler MJ; Burmeister BT; Huang Y; Hsiao EC; Salomonis N; Scott MJ; Srivastava D; Carnegie GK; Conklin BR
PLoS One; 2013; 8(4):e62705. PubMed ID: 23658642
[TBL] [Abstract][Full Text] [Related]
8. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
[TBL] [Abstract][Full Text] [Related]
9. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
10. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Niizeki T; Takeishi Y; Kitahara T; Arimoto T; Ishino M; Bilim O; Suzuki S; Sasaki T; Nakajima O; Walsh RA; Goto K; Kubota I
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H245-55. PubMed ID: 18487437
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc.
Baisamy L; Cavin S; Jurisch N; Diviani D
J Biol Chem; 2009 Oct; 284(41):28232-28242. PubMed ID: 19696020
[TBL] [Abstract][Full Text] [Related]
12. AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity.
Caso S; Maric D; Arambasic M; Cotecchia S; Diviani D
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2336-2346. PubMed ID: 28923249
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
[TBL] [Abstract][Full Text] [Related]
15. The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser(16).
Edwards HV; Scott JD; Baillie GS
Biochem J; 2012 Sep; 446(3):437-43. PubMed ID: 22731613
[TBL] [Abstract][Full Text] [Related]
16. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
17. Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading.
Oyabu J; Yamaguchi O; Hikoso S; Takeda T; Oka T; Murakawa T; Yasui H; Ueda H; Nakayama H; Taneike M; Omiya S; Shah AM; Nishida K; Otsu K
Biochem Biophys Res Commun; 2013 Nov; 441(4):787-92. PubMed ID: 24211573
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure.
Bossuyt J; Borst JM; Verberckmoes M; Bailey LRJ; Bers DM; Hegyi B
J Am Heart Assoc; 2022 Oct; 11(19):e027573. PubMed ID: 36172952
[TBL] [Abstract][Full Text] [Related]
19. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
[TBL] [Abstract][Full Text] [Related]
20. The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.
Qiao W; Zhang W; Gai Y; Zhao L; Fan J
Biochem Biophys Res Commun; 2014 Jun; 448(4):379-84. PubMed ID: 24802406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]